1/16
07:02 pm
abbv
Emmecell Appoints Ramin Valian as Chief Executive Officer to Advance Magnetic Cell Delivery Platform [Yahoo! Finance]
Low
Report
Emmecell Appoints Ramin Valian as Chief Executive Officer to Advance Magnetic Cell Delivery Platform [Yahoo! Finance]
1/16
01:43 pm
abbv
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Low
Report
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
1/16
09:03 am
abbv
Five Takeaways From The 2026 J.P. Morgan Healthcare Conference [Forbes]
Low
Report
Five Takeaways From The 2026 J.P. Morgan Healthcare Conference [Forbes]
1/16
06:27 am
abbv
AbbVie Inc.'s (NYSE:ABBV) institutional investors lost 3.3% last week but have benefitted from longer-term gains [Yahoo! Finance]
Low
Report
AbbVie Inc.'s (NYSE:ABBV) institutional investors lost 3.3% last week but have benefitted from longer-term gains [Yahoo! Finance]
1/15
01:03 pm
abbv
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Low
Report
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
1/14
06:36 pm
abbv
Top Research Reports for AbbVie, Intel & Boeing [Yahoo! Finance]
Low
Report
Top Research Reports for AbbVie, Intel & Boeing [Yahoo! Finance]
1/13
03:57 pm
abbv
AbbVie (NYSE:ABBV) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
AbbVie (NYSE:ABBV) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
1/13
12:03 pm
abbv
JPM26: J&J leans on immunology launches to fuel annual growth [Yahoo! Finance]
Low
Report
JPM26: J&J leans on immunology launches to fuel annual growth [Yahoo! Finance]
1/13
01:44 am
abbv
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans [Yahoo! Finance]
Low
Report
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans [Yahoo! Finance]
1/12
07:35 pm
abbv
Trump administration strikes deal with AbbVie to cut costs of certain drugs [CNN]
Low
Report
Trump administration strikes deal with AbbVie to cut costs of certain drugs [CNN]
1/12
06:30 pm
abbv
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans
Low
Report
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans
1/12
08:32 am
abbv
AlphaSense to Outline AI Trends Impacting Drug Discovery and R&D Investment in Biotech and Pharmaceutical Industries at Fierce JPM Week Conference [Yahoo! Finance]
Low
Report
AlphaSense to Outline AI Trends Impacting Drug Discovery and R&D Investment in Biotech and Pharmaceutical Industries at Fierce JPM Week Conference [Yahoo! Finance]
1/12
07:30 am
abbv
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
Low
Report
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
1/12
06:17 am
abbv
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States [Yahoo! Finance]
Low
Report
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States [Yahoo! Finance]
1/12
06:17 am
abbv
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie [Yahoo! Finance]
Low
Report
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie [Yahoo! Finance]
1/12
06:00 am
abbv
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States
Low
Report
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States
1/12
03:11 am
abbv
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery [Yahoo! Finance]
Low
Report
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery [Yahoo! Finance]
1/10
03:22 pm
abbv
AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research [Yahoo! Finance]
Low
Report
AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research [Yahoo! Finance]
1/10
09:39 am
abbv
MoneyShow's Best Investment Ideas For 2026: Part 1 [Seeking Alpha]
Low
Report
MoneyShow's Best Investment Ideas For 2026: Part 1 [Seeking Alpha]
1/9
07:03 pm
abbv
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund [Yahoo! Finance]
Low
Report
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund [Yahoo! Finance]
1/8
12:20 pm
abbv
AbbVie: The Dividend Does Not Lie [Seeking Alpha]
Low
Report
AbbVie: The Dividend Does Not Lie [Seeking Alpha]
1/7
10:01 pm
abbv
???????????????????????????2035????1,856?9,000???????????????? [CNET News]
Medium
Report
???????????????????????????2035????1,856?9,000???????????????? [CNET News]
1/7
09:32 pm
abbv
????????????????????????2035????256?1000????????????????? [CNET News]
Medium
Report
????????????????????????2035????256?1000????????????????? [CNET News]
1/7
08:00 am
abbv
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
Medium
Report
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
1/7
07:08 am
abbv
AbbVie (NYSE:ABBV) was given a new $240.00 price target on by analysts at UBS Group AG.
Medium
Report
AbbVie (NYSE:ABBV) was given a new $240.00 price target on by analysts at UBS Group AG.